Denali Therapeutics Inc <DNLI.O>: JPMorgan resumes coverage with overweight rating; target price $29
DNLI•Related News
Capital One Financial Corp <COF.N>: JP Morgan raises target price to $245 from $215
COF•
Leidos <LDOS.N>: JP Morgan cuts target price to $160 from $210
LDOS•
Legend Biotech Corp <LEGN.O>: JP Morgan resumes coverage with neutral rating; target price $35
LEGN•
Global Markets-Shares skid, bond yields rise as Gulf conflict sends oil surging
SPY•
No EU agreement yet on 21st Russian sanctions package, Kallas says
SPY•